The world's largest open access publisher, BioMed Central, has been sold to Springer. BioMed Central (a former sister company of The Scientist) publishes 180 peer-reviewed journals under the open access publishing model, meaning that anyone can read articles for free once they are published, and authors pay a per-page fee to publish in the journals. There are no plans to change the journal publishing costs or fees, Matt McKay, director of public relations at BioMed Central, told The Scientist. "There are no plans to change the publishing model, as part of the terms and conditions of the agreement of the board of trustees," McKay added. "We are committed to open access and the open access publishing model remains the same." Springer publishes 1,700 journals in science, technology, and medicine, and is one of three publishing groups that has a green open access policy; authors can pay a processing...
Microbial EcologyFunctional & Integrative GenomicsScientific American

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?